Concepedia

Author

Giampaolo Tortora

Agostino Gemelli University PolyclinicORCID

Also Known As

Bernardo Rocco, Christopher W. Toon, Claudio Bassi, Daniele Santini, David Torrents, Federico Cappuzzo, G T Tortora, G TORTORA, G Tortora, G. T. Tortora

1.2K

Publications

60.2K

Citations

93

H-Index

175

Concepts

All Affiliations

Agostino Gemelli University PolyclinicIstituti di Ricovero e Cura a Carattere ScientificoUniversity of VeronaUniversity of Naples Federico IIUniversità Cattolica del Sacro Cuore
GT

About

Giampaolo Tortora is an author at Agostino Gemelli University Polyclinic specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

52

135

14.8K

2

Health Sciences

13

15

723

3

Natural Sciences

7

7

288

4

Public Health

6

6

273

5

Engineering

4

4

454

Giampaolo Tortora

×

290

Publications

31.7K

Citations

74

H-Index

YearCitations

Genomic analyses identify molecular subtypes of pancreatic cancer

Peter J. Bailey, David K. Chang, Kátia Nones,

Nature

2016

3.6K

Pan-cancer analysis of whole genomes

Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse,

Nature

2020

3.1K

Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer

Talia Golan, Pascal Hammel, Michele Reni,

New England Journal of Medicine

2019

2.1K

A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.

Fortunato Ciardiello, Giampaolo Tortora

PubMed

2001

988

Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.

Fortunato Ciardiello, R. Caputo, Roberto Bianco,

PubMed

2000

938

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT)

Joaquı́n Mateo, Debyani Chakravarty, Rodrigo Dienstmann,

Annals of Oncology

2018

728

Hyperprogressive Disease in Patients With Advanced Non–Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With Single-Agent Chemotherapy

Roberto Ferrara, Laura Mezquita, Matthieu Texier,

JAMA Oncology

2018

719

Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas

Yuchen Jiao, Timothy M. Pawlik, Robert A. Anders,

Nature Genetics

2013

694

nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial

David Goldstein, Robert H. El-Maraghi, Pascal Hammel,

JNCI Journal of the National Cancer Institute

2015

656

Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.

Fortunato Ciardiello, Rosa Caputo, Roberto Bianco,

PubMed

2001

644

Page 1